Shortlist by what you need
Start here if you know why you are leaving PathAI.
Want the closest match?
ProsciaMost similar to PathAI in what it does, its category and its price.
Visit (opens Proscia in a new tab)Want the best rated?
ArteraRated 4.4 out of 5 in our review, against 4.3 for PathAI.
Visit (opens Artera in a new tab)
At a glance
Green means better than PathAI, red means worse. Prices are starting prices per month.
| Tool | Our rating | Starts at | Free plan | Best for | Compare |
|---|---|---|---|---|---|
 PathAIBaseline | 4.3 | Not listed | No | First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp | |
| Proscia | 4.3Same | Not listed | No | FDA-cleared digital pathology platform for primary diagnosis and biomarker research. | vs PathAI |
 Paige | 4.1−0.2 | Not listed | No | Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025 | vs PathAI |
| Artera | 4.4+0.1 | Not listed | No | FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. | vs PathAI |
 Aidoc | 4.4+0.1 | Not listed | No | FDA-cleared triage AI hitting 97% sensitivity, deployed in nearly 2,000 hospitals | vs PathAI |
 Rayscape | 3.7−0.6 | Not listed | No | FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm. | vs PathAI |
 AZmed | 4.4+0.1 | Not listed | No | FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays. | vs PathAI |
 InHEART | 4.2−0.1 | Not listed | No | InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk. | vs PathAI |
 InformAI | 3.9−0.4 | Not listed | No | Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products. | vs PathAI |
The alternatives in detail
In order of how closely each one matches PathAI.
Proscia
4.3Not listed
vs PathAISame
FDA-cleared digital pathology platform for primary diagnosis and biomarker research.
- FDA-cleared for primary clinical diagnosis in AP-Dx
- Concentriq AP, AP-Dx and LS configurations
- Biomarker research and clinical trial workflows
FDA clearance for primary diagnosis, not just research viewing
No published pricing
Paige
4.1Not listed
vs PathAI−0.2
Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025.
- Paige Alba AI co-pilot for digital pathology tissue-slide analysis
- Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
- Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
Research pedigree from Memorial Sloan Kettering lends real clinical credibility
Enterprise-only pricing requires a sales conversation before evaluation
Artera
4.4Not listed
vs PathAI+0.1
FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions.
- Multimodal AI trained on digitized biopsy images paired with clinical data
- FDA De Novo authorization for the ArteraAI Prostate Test
- FDA clearance for ArteraAI Breast digital pathology risk stratification
Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
Not a self-serve software product; access runs through labs, clinicians, and insurance billing
Aidoc
4.4Not listed
vs PathAI+0.1
FDA-cleared triage AI hitting 97% sensitivity, deployed in nearly 2,000 hospitals.
- AI triage scanning radiology images for time-sensitive critical findings
- FDA-cleared comprehensive triage covering 11 new plus 3 prior indications in one workflow
- 97% mean sensitivity and 98% mean specificity in the FDA pivotal study
Broad, single-workflow FDA clearance covers many conditions rather than just one
Enterprise pricing requires a sales conversation, no published self-serve rate
Rayscape
3.7Not listed
vs PathAI−0.6
FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.
- 148+ pathology detection on chest X-rays
- Pulmonary nodule detection, measurement, and tracking on lung CT
- Multiple FDA clearances and extensive clinical validation
Genuine regulatory clearance (FDA) rather than just a marketing claim
Pricing isn't public - requires direct institutional engagement
AZmed
4.4Not listed
vs PathAI+0.1
FDA-cleared AI radiology suite that flags fractures and chest abnormalities on standard X-rays.
- FDA-cleared fracture, joint effusion, and dislocation detection (AZtrauma)
- FDA-cleared chest X-ray triage for nodules, pneumothorax, and pleural effusion (AZchest)
- Pediatric and adult population coverage
Multiple FDA clearances rather than a single narrow approval
No public pricing; only reachable through a sales demo
InHEART
4.2Not listed
vs PathAI−0.1
InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk.
- AI segmentation of CT and MRI scans into interactive 3D heart models
- 24-hour turnaround from scan submission to delivered model
- FDA 510(k)-cleared AI software for cardiac image segmentation
FDA 510(k) clearance gives the AI segmentation regulatory credibility beyond a research tool
No public pricing; adoption requires a hospital procurement and contracting process
InformAI
3.9Not listed
vs PathAI−0.4
Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products.
- RadOncAI radiation therapy dose planning with FDA 510(k) clearance
- Focus on head and neck cancer treatment planning
- TransplantAI donor-recipient informatics for transplant decisions
One product has FDA 510(k) clearance, a meaningful regulatory milestone
Only RadOncAI is described as cleared; the other products are research or in development
FAQ
Questions people ask
Is PathAI free?
PathAI does not list a free plan. Check its pricing page for current plans.
How did you pick these alternatives?
We match tools on what they do, their category and their price, using the details in our directory. Ratings come from our reviews and reader reviews.